Clinical Trial Update: A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating mobocertinib capsules in people with severe kidney impairment and in healthy volunteers has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers
• Renal Impairment

Drugs mentioned

• mobocertinib (mobocertinib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Renal Impairment, Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2024-01-08